Home
Superbugs & Superdrugs USA
November 14 - November 15, 2016
Superbugs & Superdrugs USA

Superbugs & Superdrugs USA 2016

2 Day Conference: NOV 14TH & 15TH
2 Interactive Workshops: NOV 16TH (For details visit the ASSOCIATED EVENTS tab)

Broadening horizons on the growing global threat of Antimicrobial resistance (AMR) for almost two decades at the sell-out Superbugs & Superdrugs conference in Europe, SAE Media Group is thrilled to announce the expansion of its antimicrobial portfolio of events across the Atlantic with the release of Superbugs & Superdrugs USA. This year’s show in Iselin, New Jersey, will play host to an audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to discuss the latest clinical advancements and funding opportunities.

With huge interest from leaders in the field including PAHO/WHO, BARDA, NIH, Pfizer, AstraZeneca, Janssen and other senior industry representatives, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Superbugs & Superdrugs event to date.

The program will hone in on key topics such as public private partnerships, collaboration, R&D, scientific priorities for antibiotic discovery, novel antibacterial therapeutic approaches, antibiotic stewardship, rapid diagnostic tools, combination therapies, resistance prevention, plus much more!
 

FEATURED SPEAKERS

Annaliesa Anderson

Annaliesa Anderson

Vice President and CSO Bacterial Vaccines, Pfizer
Anthony Simon Lynch

Anthony Simon Lynch

Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC
Christopher Houchens

Christopher Houchens

Branch Chief, Antibacterials Program, BARDA
John Rex

John Rex

Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
Mahesh Kumar

Mahesh Kumar

Vice President, Global Biological Research and Development, Zoetis
Pilar Ramon-Pardo

Pilar Ramon-Pardo

Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
Rosemarie Aurigemma

Rosemarie Aurigemma

Chief, Biodefense Drug Development Section, DMID, NIAID, NIH

Alita Miller

Head of Bioscience, Entasis Therapeutics
Alita Miller

Annaliesa Anderson

Vice President and CSO Bacterial Vaccines, Pfizer
Annaliesa Anderson

Anthony Simon Lynch

Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC
Anthony Simon Lynch

Boris Farber

CEO, Noigel, LLC
Boris Farber

Christopher Houchens

Branch Chief, Antibacterials Program, BARDA
Christopher Houchens

Daniel Obrecht

Chief Scientific Officer, Polyphor
Daniel Obrecht

David Cook

Chief Scientific Officer , Blueberry Therapeutics Ltd.
David Cook

David Pompliano

Co-Founder and CSO, Lodo Therapeutics
David Pompliano

Domingo Gargallo-Viola

Co-Founder and CSO, ABAC Therapeutics
Domingo  Gargallo-Viola

Ian Hayter

Projects Director, Destiny Pharma Ltd
Ian Hayter

John Rex

Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca
John Rex

Mahesh Kumar

Vice President, Global Biological Research and Development, Zoetis
Mahesh Kumar

Pilar Ramon-Pardo

Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
Pilar Ramon-Pardo

Rosemarie Aurigemma

Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
Rosemarie Aurigemma

Scott Coleman

Head of Nonclinical Development, Spero Therapeutics
Scott Coleman

William Weiss

Director of Pre-Clinical Services, University of North Texas Health Science Center
William Weiss

sponsors

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Opening remarks and introductions

William Weiss

William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

Mark  Pulse

Mark Pulse, Assistant Director , University of North Texas Health Science Center

clock

9:10

Preclinical Drug Development

  • Overview of preclinical testing
  • Discovery to lead selection
  • The development model: then and now
  • Antibacterial research efforts
  • William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    Mark  Pulse

    Mark Pulse, Assistant Director , University of North Texas Health Science Center

    clock

    9:50

    Experimental Design and Methodology

  • Experimental design profoundly influences the outcome of a research study
  • Clearly define the question or problem being studied
  • Realistic objectives (achievable)
  • Choose the best research model
  • William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    Mark  Pulse

    Mark Pulse, Assistant Director , University of North Texas Health Science Center

    clock

    10:30

    Morning Coffee

    clock

    11:00

    Animal Models – Examples

  • Acute infection models – Bacteremia, Sepsis
  • Chronic infection models – Pneumonia, skin, abscesses
  • GI related – C. difficile, H. pylori
  • Device related – Biofilm, endocarditis, prosthetic joint
  • William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    Mark  Pulse

    Mark Pulse, Assistant Director , University of North Texas Health Science Center

    clock

    11:40

    Animals in Research

  • Institutional Animal Care and Use Committee (IACUC)
  • Justify why animals are necessary, minimize pain and distress, husbandry and care
  • Use of appropriate euthanasia methods
  • The 3 R’s
  • William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    Mark  Pulse

    Mark Pulse, Assistant Director , University of North Texas Health Science Center

    clock

    12:20

    Closing Remarks

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    Mark  Pulse

    Mark Pulse, Assistant Director , University of North Texas Health Science Center

    clock

    12:30

    End of Workshop

    clock

    13:30

    Registration

    clock

    14:00

    Opening remarks and introductions

    Tina Guina

    Tina Guina, Therapeutics Development Project Officer, NIAID

    Francois Franceschi

    Francois Franceschi, Therapeutics Development Program Officer, NIAID

    clock

    14:05

    Novel antibacterial therapeutics pipeline

    Francois Franceschi

    Francois Franceschi, Therapeutics Development Program Officer, NIAID

  • Overview of pipeline with focus on new classes of antibacterial antibacterial therapeutics
  • clock

    14:20

    PK/PD targets for novel antibacterials

    Thomas Lodise

    Thomas Lodise, Professor, Pharmacy Practice, Albany College of Pharmacy and Health Sciences

  • Methods for determination of PK/PD targets for clinical dosing
  • Challenges in determination of PK/PD for new classes of antibacterials
  • clock

    15:00

    Regulatory considerations for development of new antibacterials

    Ian Friedland

    Ian Friedland, Chief Medical Officer, Achaogen

  • Summary of the FDA and EMA guidance on regulatory pathways for approval of new antibacterials and harmonization
  • Overview of FDA workshop ‘Facilitating Antibacterial Drug Development for Patients with Unmet Need’
  • clock

    15:45

    Coffee

    clock

    16:00

    Challenges in clinical development of novel antibacterials – industry perspective

    John Tomayko

    John Tomayko, Chief Medical Officer, Spero Therapeutics

  • Overview of clinical development pathways 
  • Operational challenges and lessons learned
  • clock

    16:45

    The US government funding opportunities

  • Overview of funding opportunities from early research and development through late stage clinical development
  • Christopher Houchens

    Christopher Houchens, Branch Chief, Antibacterials Program, BARDA

    Tina Guina

    Tina Guina, Therapeutics Development Project Officer, NIAID

    clock

    17:00

    Discussion

    Tina Guina

    Tina Guina, Therapeutics Development Project Officer, NIAID

    Francois Franceschi

    Francois Franceschi, Therapeutics Development Program Officer, NIAID

    John Tomayko

    John Tomayko, Chief Medical Officer, Spero Therapeutics

    Christopher Houchens

    Christopher Houchens, Branch Chief, Antibacterials Program, BARDA

    clock

    17:30

    End of workshop

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    clock

    9:10

    Global action plan on antimicrobial resistance

    Pilar Ramon-Pardo

    Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO

  • Strategic lines of action
  • Progress in the development of National Action Plans
  • Barriers and challenges for implementation of the Global Action Plan
  • The way forward
  • clock

    9:50

    NIAID and National Strategy for CARB

    Rosemarie Aurigemma

    Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH

  • NIAID-supported research on antimicrobial drug resistance has helped facilitate translation of basic research discoveries from “bench to bedside”. 
  • The National Strategy for Combating Antibiotic Resistant Bacteria has allowed all facets of this drug discovery/development support to be boosted in order to drive greater interest and encourage investment and innovation.
  • NIAID hopes that the investment made will result in an upwelling of novel products into the pipeline and lead to new licensed products to stem the surge of resistant infections.
  • This presentation will describe NIAID programs that support antimicrobial product development, the results of the first year of the CARB initiative and the opportunities that lay ahead.
     
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    BARDA’s end-to-end support of antibacterial product development

    Christopher Houchens

    Christopher Houchens, Branch Chief, Antibacterials Program, BARDA

  • Launching the Biopharmaceutical Accelerator to repopulate the antimicrobial pipeline
  • Utilizing innovative public-private partnering mechanisms to stimulate clinical product development
  • Expanding the BARDA portfolio to include nontraditional antimicrobials
  • BARDA’s efforts to address objectives in the US National Action Plan for CARB
  • clock

    11:40

    Enabling drug discovery and development to address the crisis of antimicrobial resistance

    John Rex

    John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, AstraZeneca

  • New tools
  • New pathways
  • Remaining challenges
  • clock

    12:20

    Networking Lunch

    clock

    13:30

    POL7080 – Polyphor’s new class of macrocycle antibiotic

    Daniel Obrecht

    Daniel Obrecht, Chief Scientific Officer, Polyphor

  • OL7080, Murapavadin, is the frontrunner of a new class of novel macrocycle antibiotic discovered and developed by Polyphor
  • It is a Pseudomonas-specific antibiotic, highly active on a broad panel of clinical isolates, including multi-drug resistant (MDR) strains and colistin-resistant isolates.
  • Phase I clinical trial in healthy volunteers in Europe demonstrated the clinical safety and tolerability of POL7080 and a Phase II study is on-going in ventilator-associated pneumonia (VAP)
  • Polyphor is developing a novel class of broad-spectrum Gran-negative antibiotics derived from our macrocycle technology platform
  • clock

    14:10

    Antimicrobial combination therapy: Use and disuse

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

  • Rationale for the use of antibiotic combinations
  • Advantages / disadvantages of combining antimicrobial agents
  • Currently used antibiotic combinations
  • Novel and non-traditional antimicrobial combinations
  • clock

    14:50

    Innovative approaches to treating gram-negative infections

    Scott Coleman

    Scott Coleman, Head of Nonclinical Development, Spero Therapeutics

  • Turning gram-positive antibiotics into gram-negative therapeutics
  • The concept of potentiation
  • Proof of concept with generic Gram-positive agents 
  • clock

    15:30

    Afternoon Tea

    clock

    16:00

    Microbial metagenomics-based antibiotic discovery

    David Pompliano

    David Pompliano, Co-Founder and CSO, Lodo Therapeutics

  • Accessing the biosynthetic output of overlooked unculturable microbes for new medicines
  • Surveying natural variants of known secondary metabolites for improved biological and pharmaceutical properties
  • Synthetic biological manipulation of biosynthetic gene clusters as a method of lead optimization
  • clock

    16:40

    Targeting mechanisms of resistance using protein resistance neutralizers

    David Cook

    David Cook, Chief Scientific Officer , Blueberry Therapeutics Ltd.

  • Restoring antibiotic sensitivity in multi-drug resistance infections
  • Direct targeting of resistance gene products using protein “resistance neutralizers”
  • Enhance antibiotic effects, expand efficacy and maintain clinical usefulness
  • clock

    17:20

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    William Weiss

    William Weiss, Director of Pre-Clinical Services, University of North Texas Health Science Center

    clock

    9:10

    First to know and fast to market

    Mahesh Kumar

    Mahesh Kumar, Vice President, Global Biological Research and Development, Zoetis

  • Infectious diseases between animals and people
  • First to know and fast to market
  • Making a difference
  • clock

    9:50

    Novel protein-based biologics for the treatment and prevention of serious bacterial infections

    Anthony Simon Lynch

    Anthony Simon Lynch, Senior Scientific Director, Janssen Fellow & Incubator Leader, Janssen Research & Development, LLC

  • Bacteriophage-derived lysins, antibody-drug conjugates and novel protein scaffolds
  • Challenges in discovery and development
  • Potential for clinical utility as stand-alone agents or as adjuncts to existing therapies
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Progress towards developing vaccines for the prevention of Staphylococcus aureus infections

    Annaliesa Anderson

    Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer

  • Staphylococcus aureus causes serious infections in healthcare settings
  • Antibiotic resistance make infections harder to treat and non-antibiotic prophylactic approaches could address this unmet medical need 
  • Approaches to design and develop vaccines for the prevention of S. aureus infections will be discussed
  • clock

    11:40

    The novel strategy to fight multidrug resistance by multiple drugs synergism, based on docking in drug design and TRIZ

    Boris Farber

    Boris Farber, CEO, Noigel, LLC

  • The novel strategy to fight multidrug resistance
  • Multiple drugs synergism in view of multidrug resistance
  • The novel strategy to decrease antibiotics toxicity
  • clock

    12:20

    Networking Lunch

    clock

    13:30

    What can be done in order to be successful?

    Domingo  Gargallo-Viola

    Domingo Gargallo-Viola, Co-Founder and CSO, ABAC Therapeutics

  • Novel approaches and compounds
  • New scenarios in innovation
  • Rational health system
  • clock

    14:10

    Addressing the evolving challenge of ß-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broad spectrum activity against Class A, C and D enzymes

    Alita Miller

    Alita Miller, Head of Bioscience, Entasis Therapeutics

  • ETX2514 is a novel diazabicyclooctenone with potent, broad spectrum inhibitory activity against Class A, C and D serine β-lactamases
  • ETX2514 restores the antimicrobial activity of a variety of β-lactams against multi-drug resistant Gram-negative pathogens
  • The combination of ETX2514 and sulbactam is highly effective in vitro and in vivo against clinical MDR and XDR A. baumannii
  • clock

    14:50

    Afternoon Tea

    clock

    15:20

    Collaborative development of novel drugs to prevent infection

    Ian Hayter

    Ian Hayter, Projects Director, Destiny Pharma Ltd

  • Development of clinical stage assets through  collaborative ventures
  • Progression of XF-73, an alternative to traditional antibiotics
  • Preventing infection and addressing resistance
  • clock

    16:00

    Chairman’s Closing Remarks and Close of Day Two


    Head of Bioscience
    Entasis Therapeutics
    Vice President and CSO Bacterial Vaccines
    Pfizer
    Senior Scientific Director, Janssen Fellow & Incubator Leader
    Janssen Research & Development, LLC
    CEO
    Noigel, LLC
    Branch Chief, Antibacterials Program
    BARDA
    Chief Scientific Officer
    Polyphor
    Chief Scientific Officer
    Blueberry Therapeutics Ltd.
    Co-Founder and CSO
    Lodo Therapeutics
    Co-Founder and CSO
    ABAC Therapeutics
    Projects Director
    Destiny Pharma Ltd
    Senior Vice President and Chief Strategy Officer, Infection Business Unit
    AstraZeneca
    Vice President, Global Biological Research and Development
    Zoetis
    Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance
    PAHO/WHO
    Chief, Biodefense Drug Development Section
    DMID, NIAID, NIH
    Head of Nonclinical Development
    Spero Therapeutics
    Director of Pre-Clinical Services
    University of North Texas Health Science Center

    Sponsors and Exhibitors

    Official Media Partner

    Official Publication

    Supporters

    An Interview with The Medicines Company

    Download

    An Interview with Boris Farber, CEO, Noigel LLC

    Download

    Superbugs & Superdrugs USA Preliminary List of Attendees

    Download

    An Interview with Pfizer

    Download

    An Interview with Blueberry Therapeutics

    Download

    An Interview with Janssen

    Download

    An Interview With BARDA

    Download

    Past Attendees List

    Download

    Sponsors and Exhibitors


    Noigel LLC

    Sponsors and Exhibitors
    http://www.noigel.eu/

    Noigel LLC was established in 2010 by a group of scientists as the biopharmaceutical startup company to study and develop drugs based on principle multiple synergisms, based on TRIZ and modern Design and Technologies in different fields: anticancer, antiviral, antimicrobial drugs with new properties.


    Polyphor

    Sponsors and Exhibitors
    http://polyphor.com/

    Polyphor is a Swiss Pharma company focusing on the discovery and development of macrocycle drugs addressing high unmet medical needs. Macrocycles represent a new drug class complementary to the traditional small molecules and large biopharmaceuticals. Polyphor leverages its unique and proprietary technology platforms to develop its own product portfolio and to pursue licensing and collaboration opportunities with industry partners. The company’s lead drug candidates include POL6326, Balixafortide, (Phase Ib), a CXCR4 antagonist, for stem cell transplantation, tissue repair and combination treatments in oncology; POL7080, Murepavadin, (Phase II), a highly specific antibiotic with a novel mode-of-action to treat Pseudomonas infections; and POL6014 (Phase Ib), an inhaled inhibitor of neutrophil elastase for the treatment of CF and other lung diseases. Polyphor is a privately held company with about 100 employees, headquartered in Allschwil, near Basel.

    Media Partners


    American Pharmaceutical Review

    Official Media Partner
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    Colorado Bioscience

    Official Media Partner
    http://www.cobioscience.com/

    As champions for life science in our state, Colorado BioScience Association leads expansion policies to advance the industry and accelerate growth. We support a thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. CBSA fosters bioscience workforce and leadership development through opportunities for networking and professional education.


    Global Biodefense

    Official Media Partner
    http://www.globalbiodefense.com/

    Global Biodefense publishes the latest news on vaccine and therapeutics countermeasure development, biosurveillance and detection technologies, food safety and biosecurity, and CBRN incident preparedness and response. Visit our website to access daily news updates, organization profiles, conference listings, and the latest in funding opportunities for advancing biodefense technology.

    Media Partners


    Int. J. of Bioinformatics Research and Applications

    Official Publication
    http://www.inderscience.com/ijbra

    Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.


    Int. J. of Biotechnology

    Official Publication
    http://www.inderscience.com/ijbt

    IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


    International Journal of Risk Assessment and Management

    Official Publication
    http://www.inderscience.com/ijram

    IJRAM is an interdisciplinary and refereed journal that provides cross learning between: • Different business and economics, as well as scientific and technological, disciplines • Energy industries, environmental and ecological systems • Safety, public health and medical services • Software services, reliability and safety

    Media Partners


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    One Nucleus

    Supporters
    http://www.onenucleus.com

    Established in May 2010, One Nucleus is the result of the merger of ERBI and London Biotechnology Network. One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Farmavita

    Supporters
    https://farmavitar.com

    FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    Thomson Reuters

    Supporters
    http://thomsonreuters.com/products_services/science/

    Thomson Reuters is the leading source of intelligent information for professionals around the world. We provide essential information to keep you in touch with the rapidly-changing pharmaceutical and chemical markets, expert services to help you make informed, early decisions, and intuitive technology to manage and support your discovery and development activities. Our products give you the intelligence, tools and expertise to help you optimize your IP portfolio, monitor industry developments, identify licensing and partnering opportunities, deliver successful regulatory submissions, and support your scientific messaging, marketing, product positioning, and awareness campaigns.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    PMR

    Supporters
    http://www.pmrcorporate.com

    PMR (www.pmrcorporate.com) is a British-American company providing market information, advice and services to international businesses interested in Central and Eastern European countries as well as other emerging markets. PMR's key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research ). Being present on the market since 1995, offering high international standards in projects and publications, as well as providing one of the most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.


    American Laboratory

    Supporters
    http://www.americanlaboratory.com

    For laboratory managers and researchers utilizing analytical chemistry and its applications, seeking knowledge on new technologies, methods, applications, and products, the American Laboratory® publication platform provides comprehensive technology coverage for laboratory professionals at all stages of their careers. Unlike single-channel publications, American Laboratory® is a multidisciplinary resource that engages scientists through print, digital, mobile, multimedia, and social channels to provide practical information and solutions for cutting-edge results. American Laboratory® serves the need of global community of laboratory professionals for communicating relevant technical advances and insights. Globally, American Laboratory® reaches out to subscribers by offering digital distribution plus premium print in North America. Digital communications utilize internet, mobile and social channels.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Conference-Service.com

    Supporters
    http://www.conference-service.com/

    COMS is a web application for managing delegate registration, payment, paper submission and paper review. Written in Perl and C, with a MySQL database at the back end, it is a comprehensive and powerful, yet easy to use solution for online conference management.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    KBI Biopharma

    Supporters
    http://www.kbibiopharma.com

    KBI also provides services from its industry-leading Particle Characterization Core Facility, including a full range of particle detection methods and data analysis utilizing MFI, Archimedes, NTA, Helix, Morphologi G3-ID, and Viscosizer instruments.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Packaging-gateway

    Supporters
    http://www.packaging-gateway.com

    Packaging executives from around the world use the website to keep abreast of the latest industry developments and make informed purchasing decisions along the entire supply chain. Packaging-gateway.com provides up-to-date industry intelligence through: •Regularly updated news bulletins and company press releases •Feature articles written by leading industry figures •Detailed research reports containing the latest market statistics •The latest packaging related projects •White papers containing the latest analysis, insights and technology solutions


    Labhoo

    Supporters
    http://www.labhoo.com



    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


    BioPharm Insight

    Supporters
    http://www.biopharminsight.com

    BioPharm Insight is your definitive guide to the global life sciences community. Subscribers take action on forward-looking intelligence uncovered by an independent team of investigative journalists, and make strategic business decisions using the most comprehensive and powerful real-time database of market analytics and key contacts. Featuring an intuitive online interface and exclusive Active IntelT relational content technology, BioPharm Insight provides an unrivaled capability to segment and analyze the industry with detailed and searchable profiles.


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    SelectScience

    Supporters
    http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.

    Renaissance Woodbridge Hotel

    515 US Highway 1 South
    Iselin 08830
    USA

    Renaissance Woodbridge Hotel

    Your simple delights will become memorable moments at Renaissance Woodbridge Hotel. This distinctive hotel in Edison, New Jersey, features 269 modern guest rooms, including 42 suites, and more than 25,000 square feet of flexible meeting space. Our hotel's location is centrally located amidst corporate offices and tourist attraction. Our accommodations stand out from other hotels in Edison, NJ, and provide a sophisticated retreat for families and business travelers alike. Marriott's Plug-in panels and 37-inch LCD HD TVs allow guests simultaneous connectivity to laptops, iPods and DVD players. We are one of the most conveniently situated hotels at the crossroads of U.S. Routes 1 and 9. We are also just five minutes from Woodbridge Center Mall, 15 minutes south of Newark Liberty International Airport (EWR) and less than one mile from the Metropark train station. With our premier location and amenities, our Edison accommodations provide an advantageous travel destination.

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.